中国实用外科杂志

• 述评 • 上一篇    下一篇

复发性肝癌治疗方式合理选择

蔡秀军金仁安   

  1. 浙江大学医学院附属邵逸夫医院普外科,浙江杭州 310016
  • 出版日期:2019-10-01 发布日期:2019-10-10

  • Online:2019-10-01 Published:2019-10-10

摘要:

原发性肝癌术后面临着高复发率和高转移率的问题,一直制约着病人的长期生存。针对复发性肝癌的治疗,目前主要采用以手术为主导的综合治疗方案,对于无法接受手术治疗的病人,局部消融、经导管动脉化疗栓塞、放射治疗、全身化疗、靶向治疗、免疫治疗、中药、最佳支持治疗等措施是延缓肿瘤进展、改善病人生存的有效手段。根据病人的病情特点及个体化差异,开展多学科联合治疗模式,可优化肿瘤治疗效果、减少副反应,为病人带来更好的生存质量和生存时间。

关键词: 复发性肝癌, 局部消融, 放疗, 化疗, 免疫治疗

Abstract:

The optimal treatment for recurrent hepatocellular carcinoma        CAI Xiu-jun,JIN Ren-an. Department of General Surgery,Sir Run Run Shaw Hospital,Zhejiang University,Hangzhou 310016,China
Corresponding author:CAI Xiu-jun,E-mail:srrsh_cxj@zju.edu.cn
Abstract    High recurrence rate and metastasis rate after primary surgery for hepatocellular carcinoma have been restricting the long-term survival of patients. For the treatment of recurrent hepatocellular carcinoma,comprehensive treatment based on surgery is the main strategy. For patients who are unsuitable for surgery,local ablation,TACE,radiotherapy,systemic chemotherapy,targeted therapy,immunotherapy,traditional Chinese medicine and optimal supportive therapy are effective measures,which can delay disease progression and improve patient survival. According to the patient's characteristics and individual differences,the multidisciplinary treatment model should be adopted to optimize the treatment effect and reduce side effects,which will benefit the patients with better medical experience and longer overall survival rate.

Key words: recurrent hepatocellular carcinoma, local ablation, radiotherapy, chemotherapy, immunotherapy